Finasteride Tablet, Film Coated
Product Images NDC 57237-062

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Finasteride (NDC 57237-062). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rising Pharma Holdings, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 Symptom Score In A Long-term Efficacy And Safety Study (Finasteride Fig1)

This appears to be a table or figure displaying the mean change from baseline and standard error in symptom score for a long term efficacy and safety study involving a placebo and finasteride treatment. The table shows data for the baseline, year 1, year 2, year 3, and year 4 time points. No other information can be inferred from the given text.*

FDA Label Image

Figure 2 Percent Of Patients Having Surgery For Bph, Including Turp (Finasteride Fig2)

FDA Label Image

Figure 4 Prostate Volume In A Long-term Efficacy And Safety Study (Finasteride Fig3)

The text refers to Figure 3 and shows the percentage of patients who developed acute urinary retention in both the placebo group and the Finastoride group. It also provides information on the observation time and the number of events and risk per year for each group.*

FDA Label Image

Figure 5 Cumulative Incidence Of A 4-point Rise In Aua Symptom Score By Treatment Group (Finasteride Fig4)

This is a graph that shows the mean percentage change from baseline in prostate volume over four years in a long-term study that evaluated the efficacy and safety of finasteride compared to a placebo. The data is presented numerically for both treatment groups at each annual timepoint.*

FDA Label Image

Package Label-principal Display Panel (5 mg (30 Tablets Bottle))

The text represents a figure showing the cumulative incidence of a 4-Point rise in AUA Symptom Score by Treatment Group over time (in years). The graph displays the percentage of individuals experiencing this event, with treatment groups plotted on the x-axis and time on the y-axis. Unfortunately, there is no context about the study or treatments used.*

FDA Label Image

Finasteride Fig6

This is a description for a medicine called Rising® nocsm7.062.3 Esch fim-costed tablet. The tablet contains an active ingredient called Finasteride and the usual adult dosage is 5mg taken once a day. The medicine is distributed by Fossini-crm R a1. The medicine should not be used by women or children, and pregnant women should avoid this medicine. The pack contains 30 tablets and a circular with more information is included. There is also a printing zone coding area on the pack.*

FDA Label Image

Chemical Structure (Finasteride Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.